<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE topic
  PUBLIC "-//IFRS//DTD DITA Topic//EN" "../../../../DocTypes/com.ifrs.doctype/dtd/ifrsTopic.dtd">
<topic id="IFRS03_IE_TOC"><title/><body><ol reference_label="paragraph" toc_label="contents" type="toc"><li outputclass="primary"><ph outputclass="standard_ref"><ph outputclass="standard_number">IFRS 3</ph> <ph outputclass="standard_title">BUSINESS COMBINATIONS </ph></ph><linebreak/>ILLUSTRATIVE EXAMPLES</li><li><xref base="F15836617" href="IFRS03_gIE1-IE2.dita#IFRS03_gIE1-IE2" id="IFRS03_X0551">REVERSE ACQUISITIONS</xref><entry_ref>IE1</entry_ref>         <ol type="toc"><li><xref base="F15836649" href="IFRS03_gIE4-IE5.dita#IFRS03_gIE4-IE5" id="IFRS03_X0552">Calculating the fair value of the consideration transferred</xref><entry_ref>IE4</entry_ref></li><li><xref base="F15836650" href="IFRS03_gIE6-IE6.dita#IFRS03_gIE6-IE6" id="IFRS03_X0553">Measuring goodwill</xref><entry_ref>IE6</entry_ref></li><li><xref base="F15836651" href="IFRS03_gIE7-IE8.dita#IFRS03_gIE7-IE8" id="IFRS03_X0554">Consolidated statement of financial position at 30 September 20X6</xref><entry_ref>IE7</entry_ref></li><li><xref base="F15836652" href="IFRS03_gIE9-IE10.dita#IFRS03_gIE9-IE10" id="IFRS03_X0555">Earnings per share</xref><entry_ref>IE9</entry_ref></li><li><xref base="F15836653" href="IFRS03_gIE11-IE15.dita#IFRS03_gIE11-IE15" id="IFRS03_X0556">Non-controlling interest</xref><entry_ref>IE11</entry_ref></li></ol>       </li><li><xref base="F15836654" href="IFRS03_gIE16-IE44.dita#IFRS03_gIE16-IE44" id="IFRS03_X0557">IDENTIFIABLE INTANGIBLE ASSETS</xref><entry_ref>IE16</entry_ref>         <ol type="toc"><li><xref base="F15836655" href="IFRS03_gIE18-IE22.dita#IFRS03_gIE18-IE22" id="IFRS03_X0558">Marketing-related intangible assets</xref><entry_ref>IE18</entry_ref></li><li><xref base="F15836656" href="IFRS03_gIE23-IE31.dita#IFRS03_gIE23-IE31" id="IFRS03_X0559">Customer-related intangible assets</xref><entry_ref>IE23</entry_ref></li><li><xref base="F15836657" href="IFRS03_gIE32-IE33.dita#IFRS03_gIE32-IE33" id="IFRS03_X0560">Artistic-related intangible assets</xref><entry_ref>IE32</entry_ref></li><li><xref base="F15836658" href="IFRS03_gIE34-IE38.dita#IFRS03_gIE34-IE38" id="IFRS03_X0561">Contract-based intangible assets</xref><entry_ref>IE34</entry_ref></li><li><xref base="F15836689" href="IFRS03_gIE39-IE44.dita#IFRS03_gIE39-IE44" id="IFRS03_X0562">Technology-based intangible assets</xref><entry_ref>IE39</entry_ref></li></ol>       </li><li><xref base="F15836690" href="IFRS03_gIE44A-IE44J.dita#IFRS03_gIE44A-IE44J" id="IFRS03_X0563">MEASUREMENT OF NON-CONTROLLING INTEREST (NCI)</xref><entry_ref>IE44A</entry_ref>         <ol type="toc"><li><xref base="F15836691" href="IFRS03_gIE44B-IE44E.dita#IFRS03_gIE44B-IE44E" id="IFRS03_X0564">Measurement of NCI including preference shares</xref><entry_ref>IE44B</entry_ref></li><li><xref base="F15836692" href="IFRS03_gIE44F-IE44G.dita#IFRS03_gIE44F-IE44G" id="IFRS03_X0565">First variation</xref><entry_ref>IE44F</entry_ref></li><li><xref base="F15836693" href="IFRS03_gIE44H-IE44J.dita#IFRS03_gIE44H-IE44J" id="IFRS03_X0566">Second variation</xref><entry_ref>IE44H</entry_ref></li></ol>       </li><li><xref base="F15836694" href="IFRS03_gIE45-IE49.dita#IFRS03_gIE45-IE49" id="IFRS03_X0567">GAIN ON A BARGAIN PURCHASE</xref><entry_ref>IE45</entry_ref></li><li><xref base="F15836695" href="IFRS03_gIE50-IE53.dita#IFRS03_gIE50-IE53" id="IFRS03_X0568">MEASUREMENT PERIOD</xref><entry_ref>IE50</entry_ref></li><li><xref base="F35713783" href="IFRS03_gIE54-IE71.dita#IFRS03_gIE54-IE71/IFRS03_gIE54-IE71_TI" id="IFRS03_X0569">DETERMINING WHAT IS PART OF THE BUSINESS COMBINATION TRANSACTION</xref><entry_ref>IE54</entry_ref>         <ol type="toc"><li><xref base="F15836697" href="IFRS03_gIE54-IE57.dita#IFRS03_gIE54-IE57" id="IFRS03_X0570">Settlement of a pre-existing relationship</xref><entry_ref>IE54</entry_ref></li><li><xref base="F15836729" href="IFRS03_gIE58-IE60.dita#IFRS03_gIE58-IE60" id="IFRS03_X0571">Contingent payments to employees</xref><entry_ref>IE58</entry_ref></li><li><xref base="F15836730" href="IFRS03_gIE61-IE71.dita#IFRS03_gIE61-IE71" id="IFRS03_X0572">Replacement awards</xref><entry_ref>IE61</entry_ref></li></ol>       </li><li><xref base="F15836731" href="IFRS03_gIE72-IE72.dita#IFRS03_gIE72-IE72" id="IFRS03_X0573">DISCLOSURE REQUIREMENTS</xref><entry_ref>IE72</entry_ref></li><li><xref href="IFRS03_gIE73-IE123.dita" scope="local">Definition of a business</xref><entry_ref>IE73</entry_ref>         <ol type="toc"><li><xref href="IFRS03_gIE74-IE86.dita" scope="local">Example A&#x2014;acquisition of real estate</xref><entry_ref>IE74</entry_ref></li><li><xref href="IFRS03_gIE87-IE92.dita" scope="local">Example B&#x2014;acquisition of a drug candidate</xref><entry_ref>IE87</entry_ref></li><li><xref href="IFRS03_gIE93-IE97.dita" scope="local">Example C&#x2014;acquisition of a biotech entity</xref><entry_ref>IE93</entry_ref></li><li><xref href="IFRS03_gIE98-IE100.dita" scope="local">Example D&#x2014;acquisition of a television station</xref><entry_ref>IE98</entry_ref></li><li><xref href="IFRS03_gIE101-IE103.dita" scope="local">Example E&#x2014;acquisition of a closed manufacturing facility</xref><entry_ref>IE101</entry_ref></li><li><xref href="IFRS03_gIE104-IE106.dita" scope="local">Example F&#x2014;licence of distribution rights</xref><entry_ref>IE104</entry_ref></li><li><xref href="IFRS03_gIE107-IE109.dita" scope="local">Example G&#x2014;acquisition of brands</xref><entry_ref>IE107</entry_ref></li><li><xref href="IFRS03_gIE110-IE117.dita" scope="local">Example H&#x2014;acquisition of loan portfolio</xref><entry_ref>IE110</entry_ref></li><li><xref href="IFRS03_gIE118-IE123.dita" scope="local">Example I&#x2014;determining the fair value of the gross assets acquired</xref><entry_ref>IE118</entry_ref></li></ol>       </li><li outputclass="keep_with_next"><xref base="F15836616" href="IFRS03_IE_APP.dita#IFRS03_IE_APP" id="IFRS03_X0575">APPENDIX</xref>         <ol type="toc"><li><xref base="F15836615" href="IFRS03_IE_APP.dita#IFRS03_IE_APP" id="IFRS03_X0576">Amendments to guidance on other IFRSs</xref><entry_ref> </entry_ref></li></ol>       </li></ol></body></topic>